These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 38454739)

  • 1. Loop diuretic down-titration at discharge in patients hospitalized for acute heart failure.
    Croset F; Llàcer P; Núñez J; Campos J; García M; Pérez A; Fernández C; Fabregate M; López G; Tello S; Fernández JM; Ruiz R; Manzano L
    ESC Heart Fail; 2024 Jun; 11(3):1739-1747. PubMed ID: 38454739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loop diuretic down-titration in stable chronic heart failure is often achievable, especially when urinary chloride concentration is low.
    Verbrugge FH; Martens P; Boonen L; Nijst P; Verhaert D; Noyens P; De Vusser P; Dupont M; Tang WHW; Mullens W
    Acta Cardiol; 2018 Aug; 73(4):335-341. PubMed ID: 28971753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous Diuretic Therapy for the Management of Heart Failure and Volume Overload in a Multidisciplinary Outpatient Unit.
    Buckley LF; Carter DM; Matta L; Cheng JW; Stevens C; Belenkiy RM; Burpee LJ; Young MA; Weiffenbach CS; Smallwood JA; Stevenson LW; Desai AS
    JACC Heart Fail; 2016 Jan; 4(1):1-8. PubMed ID: 26656139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-Hospital Diuretic Agent Use and Post-Discharge Clinical Outcomes in Patients Hospitalized for Worsening Heart Failure: Insights From the EVEREST Trial.
    Mecklai A; Subačius H; Konstam MA; Gheorghiade M; Butler J; Ambrosy AP; Katz SD
    JACC Heart Fail; 2016 Jul; 4(7):580-588. PubMed ID: 27039131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of Diuretic Responsiveness and Associated Outcomes During Acute Heart Failure Hospitalization: An Analysis From the NHLBI Heart Failure Network Clinical Trials.
    Kiernan MS; Stevens SR; Tang WHW; Butler J; Anstrom KJ; Birati EY; Grodin JL; Gupta D; Margulies KB; LaRue S; Dávila-Román VG; Hernandez AF; de las Fuentes L;
    J Card Fail; 2018 Jul; 24(7):428-438. PubMed ID: 29482026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diuretic use and outcomes in patients with heart failure with reduced ejection fraction: Insights from the VICTORIA trial.
    Ezekowitz J; Alemayehu W; Edelmann F; Ponikowski P; Lam CSP; O'Connor CM; Butler J; Corda S; McMullan CJ; Westerhout CM; Voors AA; Mentz RJ; Armstrong PW;
    Eur J Heart Fail; 2024 Mar; 26(3):628-637. PubMed ID: 38450878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in Loop Diuretic Dose and Outcome After Cardiac Resynchronization Therapy in Patients With Heart Failure and Reduced Left Ventricular Ejection Fractions.
    Martens P; Verbrugge FH; Nijst P; Dupont M; Mullens W
    Am J Cardiol; 2017 Jul; 120(2):267-273. PubMed ID: 28532770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of Discharged Loop Diuretic Dose to Home Dose on Hospital Readmissions in Patients with Acute Decompensated Heart Failure: A Retrospective Cohort Study.
    Alshibani M; Alshehri S; Alyazidi W; Alnomani A; Almatruk Z; Almeleebia T
    Heart Surg Forum; 2020 Jul; 23(4):E470-E474. PubMed ID: 32726210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential mortality association of loop diuretic dosage according to blood urea nitrogen and carbohydrate antigen 125 following a hospitalization for acute heart failure.
    Núñez J; Núñez E; Miñana G; Bodí V; Fonarow GC; Bertomeu-González V; Palau P; Merlos P; Ventura S; Chorro FJ; Llàcer P; Sanchis J
    Eur J Heart Fail; 2012 Sep; 14(9):974-84. PubMed ID: 22700856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes Associated With a Strategy of Adjuvant Metolazone or High-Dose Loop Diuretics in Acute Decompensated Heart Failure: A Propensity Analysis.
    Brisco-Bacik MA; Ter Maaten JM; Houser SR; Vedage NA; Rao V; Ahmad T; Wilson FP; Testani JM
    J Am Heart Assoc; 2018 Sep; 7(18):e009149. PubMed ID: 30371181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensification of pharmacological decongestion but not the actual daily loop diuretic dose predicts worse chronic heart failure outcome: insights from TIME-CHF.
    Simonavičius J; Maeder MT; Eurlings CGMJ; Aizpurua AB; Čelutkienė J; Barysienė J; Toggweiler S; Kaufmann BA; Brunner-La Rocca HP
    Clin Res Cardiol; 2021 Aug; 110(8):1221-1233. PubMed ID: 33216179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and baseline characteristics of SALT-HF trial: hypertonic saline therapy in ambulatory heart failure.
    Cobo Marcos M; Comín-Colet J; de la Espriella R; Rubio Gracia J; Morales-Rull JL; Zegrí I; Llacer P; Diez-Villanueva P; Jiménez-Marrero S; de Juan Bagudá J; Ortiz Cortés C; Goirigolzarri-Artaza J; García-Pinilla JM; Barrios E; Del Prado Díaz S; Montero Hernández E; Sanchez-Marteles M; Nuñez J
    ESC Heart Fail; 2024 Jun; 11(3):1767-1776. PubMed ID: 38380837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between high-dose loop diuretic use at discharge and cardiovascular mortality in patients with heart failure.
    Okabe T; Yakushiji T; Kido T; Oyama Y; Igawa W; Ono M; Ebara S; Yamashita K; Yamamoto MH; Saito S; Amemiya K; Isomura N; Ochiai M
    ESC Heart Fail; 2018 Feb; 5(1):87-94. PubMed ID: 28967699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationale and study design of intravenous loop diuretic administration in acute heart failure: DIUR-AHF.
    Palazzuoli A; Ruocco G; Vescovo G; Valle R; Di Somma S; Nuti R
    ESC Heart Fail; 2017 Nov; 4(4):479-486. PubMed ID: 28980452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loop diuretic dose adjustments after a hospitalization for heart failure: insights from ASCEND-HF.
    DeVore AD; Hasselblad V; Mentz RJ; O'Connor CM; Armstrong PW; McMurray JJ; Ezekowitz JA; Tang WH; Starling RC; Voors AA; Califf RM; Hernandez AF
    Eur J Heart Fail; 2015 Mar; 17(3):340-6. PubMed ID: 25619549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher doses of loop diuretics limit uptitration of angiotensin-converting enzyme inhibitors in patients with heart failure and reduced ejection fraction.
    Ter Maaten JM; Martens P; Damman K; Dickstein K; Ponikowski P; Lang CC; Ng LL; Anker SD; Samani NJ; Filippatos G; Cleland JG; Zannad F; Hillege HL; van Veldhuisen DJ; Metra M; Voors AA; Mullens W
    Clin Res Cardiol; 2020 Aug; 109(8):1048-1059. PubMed ID: 32002631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of admission oral diuretic dose on response to continuous versus bolus intravenous diuretics in acute heart failure: an analysis from diuretic optimization strategies in acute heart failure.
    Shah RV; McNulty S; O'Connor CM; Felker GM; Braunwald E; Givertz MM
    Am Heart J; 2012 Dec; 164(6):862-8. PubMed ID: 23194486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diuretic therapy as prognostic enrichment factor for clinical trials in patients with heart failure with reduced ejection fraction.
    Coiro S; Girerd N; McMurray JJV; Pitt B; Swedberg K; van Veldhuisen DJ; Lamiral Z; Rossignol P; Zannad F
    Clin Res Cardiol; 2021 Aug; 110(8):1308-1320. PubMed ID: 33956209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discharge Diuretic Dose and 30-Day Readmission Rate in Acute Decompensated Heart Failure.
    Woodruff AE; Kelley AM; Hempel CA; Loeffler WJ; Echtenkamp CA; Hassan AK
    Ann Pharmacother; 2016 Jun; 50(6):437-45. PubMed ID: 26956954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung ultrasound and diuretic therapy in chronic heart failure: a randomised trial.
    Cruz M; Ferreira JP; Diaz SO; Ferrão D; Ferreira AI; Girerd N; Sampaio F; Pimenta J
    Clin Res Cardiol; 2024 Mar; 113(3):425-432. PubMed ID: 37289237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.